The detection of human papillomavirus in head and neck cancers

Publication Type:
Thesis
Issue Date:
2023
Full metadata record
Head and neck cancer (HNC) ranks as the sixth most common cancer globally, with 5-year survival rates below 50% for late-stage diagnoses. Recent years have seen a surge in cases linked to the human papillomavirus (HPV), particularly HPV16, which is implicated in over 85% of oropharyngeal cancers (OPC). Given the distinct epidemiological and molecular profiles of HPV-related OPC, precise diagnostics for active HPV are crucial. This doctoral research developed a multiplex assay for HPV16 RNA oncogenes E6 and E7 detection in saliva from OPC patients in Sydney, demonstrating comparable efficiency to traditional methods and a reliable detection threshold. The research extended into bioinformatics due to COVID-19, analysing HNC trends in Southeast Asia using data from the Ho Chi Minh Cancer Registry (1996-2015). The study identified rising incidence rates of oropharyngeal and oral cancers in Vietnam, with nasopharyngeal cancer being disproportionately high compared to other Southeast Asian countries. Interestingly, the age-standardised rate (ASR) for oropharyngeal cancer matched global figures, underscoring the need for expanded HPV vaccination and screening strategies in Vietnam. This work not only introduces a novel non-invasive diagnostic tool but also provides the first comprehensive characterisation of HNC epidemiology in Ho Chi Minh City, highlighting significant subtype-specific trends.
Please use this identifier to cite or link to this item: